Cargando…
The gut fungal and bacterial microbiota in pediatric patients with inflammatory bowel disease introduced to treatment with anti-tumor necrosis factor-α
Pediatric inflammatory bowel disease (PIBD) is a globally increasing chronic inflammatory disease associated with an imbalanced intestinal microbiota and treated with several treatment options, including anti-tumor necrosis factor alpha (TNF-α), such as infliximab (IFX). Up to half of the patients d...
Autores principales: | Ventin-Holmberg, Rebecka, Höyhtyä, Miikka, Saqib, Schahzad, Korpela, Katri, Nikkonen, Anne, Salonen, Anne, de Vos, Willem M., Kolho, Kaija-Leena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033777/ https://www.ncbi.nlm.nih.gov/pubmed/35459927 http://dx.doi.org/10.1038/s41598-022-10548-7 |
Ejemplares similares
-
The Effect of Antibiotics on the Infant Gut Fungal Microbiota
por: Ventin-Holmberg, Rebecka, et al.
Publicado: (2022) -
Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel Disease
por: Höyhtyä, Miikka, et al.
Publicado: (2022) -
Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease
por: Wedenoja, Satu, et al.
Publicado: (2022) -
Quantitative insights into effects of intrapartum antibiotics and birth mode on infant gut microbiota in relation to well-being during the first year of life
por: Jokela, Roosa, et al.
Publicado: (2022) -
Cohort profile: Finnish Health and Early Life Microbiota (HELMi) longitudinal birth cohort
por: Korpela, Katri, et al.
Publicado: (2019)